About: The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 09 October 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2007 (uk) article scientifique publié en 2007 (fr) im Oktober 2007 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 2007 (ast) scientific article published on 09 October 2007 (en)
publication date	wds:Q81502449-5A7E29C1-C20D-489C-A9AB-8CA4B77706F2
publication date	2007-10-09 00:00:00Z (xsd:dateTime)
cites work	wds:Q81502449-16EF8240-87C0-4E8A-8859-D0B5B8C2DFF8 wds:Q81502449-185D45D6-8E98-42C7-9B37-8B4F39BDF976 wds:Q81502449-19AA183A-0131-40A2-86C3-53B177595BAF wds:Q81502449-2227CBEC-F4A8-4FA3-BE6A-12BA08C860FC wds:Q81502449-24432D32-85D1-4F9C-BCC6-3D6932D15F88 wds:Q81502449-3C757EC7-291F-409E-8E51-FD1DA77A4AE1 wds:Q81502449-41B65E93-CC2E-4FB4-9704-D771C1C96A58 wds:Q81502449-4D54552B-97E1-4286-ADC3-468AE2822435 wds:Q81502449-52EB0245-2A9A-484A-BB6D-0CB771186ABB wds:Q81502449-6A476893-AAED-4514-AAA1-A55425E1A299 wds:Q81502449-78D88C72-E3DC-46AD-9555-107460ABFE93 wds:Q81502449-828A6F6F-9D66-494B-8E9D-8E5C3DD1E021 wds:Q81502449-89E8FFD3-9828-47DB-B9BC-36C6A0D19DFC wds:Q81502449-8C02316F-E8BC-4AA4-A4F8-C3A8CEB466E5 wds:Q81502449-911F7DD0-E6E5-44E8-9D37-C9443763FBB9 wds:Q81502449-B2778EE1-6EA3-4B95-A5C2-39D10721DC40 wds:Q81502449-BBBF3769-73E8-4DCC-AC72-7D3874075588 wds:Q81502449-C5CFBE5B-1B7C-4903-BD61-B148EAD8B2B8 wds:Q81502449-DC3D2437-6FCD-4D94-84C7-A1397A93AE35 wds:Q81502449-DF9B3D8D-0B00-42ED-88E4-95BAB35D84B1 wds:Q81502449-F931B5D3-F927-4B4C-B439-8A125FDC1197 wds:Q81502449-F96EC2AA-535D-4228-B3D3-56750831DA62
cites work	The Gambian Haemophilus influenzae type b vaccine trial: what does it tell us about the burden of Haemophilus influenzae type b disease? Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate) Development and clinical application of new polyvalent combined paediatric vaccines Standard and alternative regimens of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate vaccine) elicit comparable antibody avidities in infants Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America The use of combination vaccines has improved timeliness of vaccination in children Hepatitis B virus infection in children Status of hepatitis B immunization programmes in 1998 Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization Hepatitis B component does not interfere with the immune response to diphtheria, tetanus and whole-cell Bordetella pertussis components of a quadrivalent (DTPw-HB) vaccine: a controlled trial in healthy infants Immune response to a combined hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine administered to infants at 2, 4 and 6 months of age Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b Do too many shots due lead to missed vaccination opportunities? Does it matter? Immunogenicity and reactogenicity of a combined DTPw-hepatitis B vaccine in Lithuanian infants Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B Double-blind study comparing the immunogenicity of a licensed DTwPHib-CRM197 conjugate vaccine (Quattvaxem) with three investigational, liquid formulations using lower doses of Hib-CRM197 conjugate
author name string	wds:Q81502449-0E5907D5-00D0-49E1-B593-9E11B63E63A5 wds:Q81502449-0EB6711B-1BBE-485C-9F94-93C5840336B9 wds:Q81502449-12C1CB1B-F7D9-45B4-AAE1-DF8AF20D556D wds:Q81502449-3159C1E3-4B04-47B4-B21C-4821B0E03D04 wds:Q81502449-753946A9-0641-4B28-A6D2-54DB74A0ABCA wds:Q81502449-A134E8C2-2D9C-41B6-A251-47E990B79A0B
author name string	Inge Lefevre Güler Kanra Assad Safary DTPw-HBV/Hib 2.5 study group Eduardo Ortega-Barrìa Geert Leroux
rdfs:label	The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents (en) The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents (nl)
skos:prefLabel	The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents (en) The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents (nl)
name	The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents (en) The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents (nl)
author	wds:Q81502449-660D320B-3545-410F-9277-5DD63F7C1000
author	Lulu Bravo
title	wds:Q81502449-B4852D50-ECC6-4BCA-BE21-A3DE92A42A1E
title	The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents (en)
page(s)	wds:Q81502449-ACA5F892-1BC6-4BC0-8E16-653B77528714
page(s)	8432-8440
instance of	wds:Q81502449-A10D7B5A-BBA6-45D0-9C81-931F12836901
instance of	scholarly article
main subject	wds:Q81502449-69BF0C91-2A28-4EEB-9040-5AF857D4C5A6 wds:Q81502449-B5DF45D7-E5D1-45C1-A2CD-8C34D3D6DF78
main subject	multicenter clinical trial phase III clinical trial
PubMed ID	wds:Q81502449-06E3DD9D-5CF5-4341-9E44-4E3AA84883CE
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17961876
PubMed ID	17961876
published in	wds:Q81502449-B3B27005-466C-438A-82EA-C95A1D363BB2
published in	Vaccine
issue	wds:Q81502449-D0211EDB-463F-4B95-BC8C-C2367323CEC4
volume	wds:Q81502449-6D243469-3C85-40E0-83A7-1BACC3A6C45E
issue	50
volume	25
DOI	wds:Q81502449-27AA7AEB-F9EB-4924-A7D1-8385CBB6A5EF
DOI	http://dx.doi.org/10.1016/J.VACCINE.2007.09.045
DOI	10.1016/J.VACCINE.2007.09.045
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81502449
is cites work of	Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys. Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB) Interchangeability of Quinvaxem during primary vaccination schedules: results from a phase IV, single-blind, randomized, controlled, single-center, non-inferiority study

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software